Search clinical trials for: 0.07% Cetylpyridinium chloride

Total 4129 results

Aziende Chimiche Riunite Angelini Francesco S.p.A
Cross Research S.A.

Completed

A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer

Healthy

Switzerland
University of British Columbia

Withdrawn

Assessing the Effect of Periodontal Debridement, Tongue Cleaning and Mouth Rinsing for the Treatment of Oral Malodour

Halitosis
Tufts University

Completed

Dental Implants and Mouth Rinse

Reduction in Bacterial Counts Through the Use of Mouthwash

United States
Dentaid SL
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la... and other collaborators

Completed

Double-blind, Randomized, Parallel, Placebo-controlled Clinical Study to Evaluate the Viral Load of SARS-CoV-2 (COVID-19) in the Oral Cavity of SARS-CoV-2 Positive Subjects After the Use of a Mouthwash Containing Cetylpyridinium Chloride 0,07%. (CPC COVID)

SARS-CoV-2 Infection

Spain
The University of Texas Health Science Center,...
CONFADENT Oral Technology, Kiss Industries LLC

Completed

Cetylpyridium Chloride (CPC) Based Chewing Gum and Gingivitis

Periodontal Diseases | Gingivitis | Plaque, Dental

United States
University of Siena

Recruiting

Clinical and Microbiological Comparison of 0.2% CHX and 0.05% CHX+0.05%CPC Mouthwashes in TPS Patients

Periodontitis | Gingivitis | Chlorhexidine | Cetylpyridinium Chloride

Italy
Peking University People's Hospital

Completed

Salivary Drug Concentration Exploratory Study of Cetylpyridinium Chloride Buccal Tablets

Gingivitis | Pharyngitis Acute

China
Gangnam Severance Hospital

Completed

Remimazolam Bolus for General Anesthesia

Loss of Consciousness

Korea, Republic of
Rosa Tarrago
Dentaid SL

Completed

Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19

COVID-19 | SARS-CoV-2 Infection

Spain
University of Illinois at Chicago

Completed

Effect of Mouthwashes on Oral Wound Healing and Microbiome

Wound Heal | Oral Microbiome

United States
University of Toledo Health Science Campus
ProMedica Health System; The University of Toledo; ARMS Pharmaceutical LLC; Pediatric...

Withdrawn

ARMS-I (a Formulation of Cetylpyridinium Chloride -CPC) (ARMS-I)

Viral Upper Respiratory Tract Infection

United States
Pfizer

Completed

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Plaque Psoriasis | Atopic Dermatitis

United States, Canada, United Kingdom, Japan
University of North Carolina, Chapel Hill

Recruiting

Efficacy of Oral Rinses for Inactivation of COVID-19 (MOR2) (MOR2)

COVID-19 | Coronavirus Infection | SARS CoV 2 Infection

United States
Seoul National University Hospital

Completed

Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia (CPC2)

Sarcopenia

Korea, Republic of
Seoul National University Hospital

Completed

Preventive Effects of Cetylpyridinium Chloride on SarcopeniaStudy

Sarcopenia
Sanofi

Completed

Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power

Healthy

Brazil
Eisai Limited

Completed

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
Procter and Gamble

Completed

A Controlled Clinical Study to Determine the Gingivitis Benefit of Flossing

Gingivitis

United States, Guatemala
University of Taubate

Unknown

Mouthwashes During Orthodontic Treatment (MOUORT)

Gingivitis

Brazil
Sanofi

Completed

Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen. (Cepacol Teen)

Hygiene

Brazil
Johns Hopkins Bloomberg School of Public Health
Bill and Melinda Gates Foundation

Completed

Feasibility and Acceptability of Use of Daily Oral Rinse in Pregnant Women in Rural Nepal

Periodontitis | Premature Birth of Newborn

Nepal
Galderma R&D

Completed

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (CTCL)

Cutaneous T Cell Lymphoma

United States, France, Germany
Spirig Pharma Ltd.

Completed

Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions

Actinic Keratosis

Switzerland, Germany
Abramson Cancer Center of the University of Pennsylvania

Completed

Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)

Cutaneous T Cell Lymphoma

United States
Allergan

Completed

A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Eisai Inc.

Completed

Paired-Comparison Study Evaluating the Efficacy and Safety of E6201 Versus Vehicle for the Treatment of Plaque-Type Psoriasis

Chronic Plaque Psoriasis

United States
SCAI Therapeutics

Completed

Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

Dry Eye Syndromes

Korea, Republic of
University of North Carolina, Chapel Hill

Terminated

Mouth Rinses for Inactivation of COVID-19 (MOR)

Coronavirus Infection | Covid19 | SARS-CoV-2 Infection

United States
University of California, San Francisco
Rowpar Pharmaceuticals, Inc.

Terminated

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) (AMPoL)

Coronavirus Infections | COVID-19 | SARS-CoV 2 | Pharyngeal Diseases | Severe Acute Respiratory Syndrome Coronavirus 2 | Virus Disease

United States
AstraZeneca

Completed

Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Non-Insulin-Dependent

United States
NuvOx LLC
University of Arkansas

Completed

A Phase Ib/II in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
Aerie Pharmaceuticals

Completed

Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan

Ocular Hypertension | Open Angle Glaucoma

Japan
Utrecht Institute for Pharmaceutical Sciences

Completed

Effects of Alcohol on Simulated Driving

Alcoholism

Netherlands
Martin W. Case
University of North Carolina

Recruiting

Pulmonary and Inflammatory Responses Following Exposure to a Low Concentration of Ozone or Clean Air (LOCONOZ2)

Symptoms and Signs | Lung Injury, Acute | Neutrophilia Acute

United States
Islamic Azad University, Tehran

Completed

A Comparison of Mouth Rinse Containing Alcohol-free Chlorhexidine With a Cetylpyridinium Chloride in Periodontal Diseases

Periodontal Diseases
SIFI SpA

Completed

Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects

Acanthamoeba Keratitis
Allergan

Completed

A Study of AGN-195263 for the Treatment of Meibomian Gland Dysfunction

Meibomian Gland Dysfunction

United States
Aerie Pharmaceuticals

Completed

Study of AR-13324 in Patients With Elevated Intraocular Pressure

Ocular Hypertension | Open Angle Glaucoma

United States
Sun Pharmaceutical Industries Limited

Completed

Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Keratoconjunctivitis Sicca | Dry Eye Disease

United States
Colgate Palmolive

Completed

The Clinical Efficacy of Three Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste and a Mouthwash in Controlling Dental Plaque and Gingivitis

Gingivitis | Dental Plaque

Puerto Rico
Allergan

Completed

Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution

Ocular Hypertension | Glaucoma, Open-Angle

United States
Cairo University

Not yet recruiting

Effect of Apical Enlargement to Different Preparation Sizes and Tapers on Pain and Bacterial Reduction in Necrotic Pulp

Necrotic Pulp
Allergan

Completed

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

Spain, France, Belgium, Israel, United Kingdom, Poland, Italy, Czechia, Germany, Hungary
Allergan

Completed

Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Allergan

Completed

Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma

United States
Procter and Gamble

Completed

Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM) (OHMOM)

Gingivitis | Pregnancy

United States
Fundación para el Fomento de la Investigación Sanitaria...
Hospital Universitario Virgen de la Arrixaca; Hospital Universitario Fundación... and other collaborators

Completed

Antiseptic Mouth Rinses to Reduce Salivary Viral Load in COVID-19 Patients (BUCOSARS)

Covid19

Spain
Jinyang Li

Completed

Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome (BCL)

Sjögren's Syndrome Patients With Severe Dry Eye

China
Queen Mary University of London
GlaxoSmithKline

Completed

Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva (COVID-19)

Covid19 | Coronavirus

United Kingdom
Iperboreal Pharma Srl

Terminated

Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD

End Stage Renal Disease

Italy

3

Subscribe